Arneson-Wissink Paige C, Pelz Katherine, Worley Beth, Mendez Heike, Pham Peter, McCarthy Grace, Chitsazan Alex, Brody Jonathan R, Grossberg Aaron J
Brenden-Colson Center for Pancreatic Care, Oregon Health & Science University, Portland, OR.
Department of Radiation Medicine, Oregon Health & Science University, Portland, OR.
bioRxiv. 2024 Dec 27:2024.12.27.630549. doi: 10.1101/2024.12.27.630549.
Cachexia is defined by chronic loss of fat and muscle, is a frequent complication of pancreatic ductal adenocarcinoma (PDAC), and negatively impacts patient outcomes. Nutritional supplementation cannot fully reverse tissue wasting, and the mechanisms underlying this phenotype are unclear. This work aims to define the relative contributions of catabolism and anabolism to adipose wasting in PDAC-bearing mice. Human antigen R (HuR) is an RNA-binding protein recently shown to suppress adipogenesis. We hypothesize that fat wasting results from a loss of adipose anabolism driven by increased HuR activity in adipocytes of PDAC-bearing mice.
Adult C57BL/6J mice received orthotopic PDAC cell ( ) (OT-PDAC) or PBS (sham) injections. Mice exhibiting moderate cachexia (9 days after injection) were fasted for 24h, or fasted 24h and refed 24h before euthanasia. A separate cohort of PDAC mice were treated with an established HuR inhibitor (KH-3, 100 mg/kg) and subjected to the fast/refeed paradigm. We analyzed body mass, gross fat pad mass, and adipose tissue mRNA expression. We quantified lipolytic rate as the normalized quantity of glycerol released from 3T3-L1 adipocytes , and gonadal fat pads (gWAT) .
3T3-L1 adipocytes treated with PDAC cell conditioned media (CM) liberated less triglyceride into the culture media than control-treated adipocytes (-28.1%) and had lower expression of lipolysis and lipogenesis genes than control cells. PDAC gWAT cultured displayed decreased lipolysis compared to sham gWAT (-54.7%). PDAC and sham mice lost equivalent fat mass after a 24h fast, however, PDAC mice could not restore inguinal fat pads (iWAT) (-40.5%) or gWAT (-31.8%) mass after refeeding. RNAseq revealed 572 differentially expressed genes in gWAT from PDAC compared to sham mice. Downregulated genes (n=126) were associated with adipogenesis (adj p=0.05), and expression of adipogenesis master regulators and were reduced in gWAT from PDAC mice. Immunohistochemistry revealed increased HuR staining in gWAT (+74.9%) and iWAT (+41.2%) from PDAC mice. Inhibiting HuR binding restored lipogenesis in refed animals with a concomitant increase in iWAT mass (+131.7%) and genes regulating adipogenesis (, , , , ).
Our work highlights deficient adipose anabolism as a driver of wasting in 3T3-L1 adipocytes treated with PDAC conditioned media and OT-PDAC mice. The small molecule KH3, which disrupts HuR binding, was sufficient to restore adipogenic and lipogenic gene expression and prevent adipose wasting. This highlights HuR as a potentially targetable regulatory node for adipose anabolism in cancer cachexia.
恶病质的定义为脂肪和肌肉的慢性丢失,是胰腺导管腺癌(PDAC)的常见并发症,对患者预后产生负面影响。营养补充不能完全逆转组织消瘦,且这种表型的潜在机制尚不清楚。本研究旨在确定分解代谢和合成代谢对荷PDAC小鼠脂肪消耗的相对贡献。人类抗原R(HuR)是一种RNA结合蛋白,最近被证明可抑制脂肪生成。我们假设脂肪消耗是由于荷PDAC小鼠脂肪细胞中HuR活性增加导致脂肪合成代谢丧失所致。
成年C57BL/6J小鼠接受原位PDAC细胞( )(OT-PDAC)或PBS(假手术)注射。表现出中度恶病质(注射后9天)的小鼠在安乐死前行24小时禁食,或禁食24小时后再喂食24小时。另一组PDAC小鼠用已证实的HuR抑制剂(KH-3,100mg/kg)处理,并采用禁食/再喂食模式。我们分析了体重、总脂肪垫质量和脂肪组织mRNA表达。我们将脂解速率定量为从3T3-L1脂肪细胞和性腺脂肪垫(gWAT)释放的甘油的标准化量。
用PDAC细胞条件培养基(CM)处理的3T3-L1脂肪细胞向培养基中释放的甘油三酯比对照处理的脂肪细胞少(-28.1%),且脂解和脂肪生成基因的表达低于对照细胞。与假手术gWAT相比,PDAC gWAT培养物显示脂解减少(-54.7%)。PDAC和假手术小鼠在禁食24小时后脂肪量减少相当,然而,PDAC小鼠在再喂食后不能恢复腹股沟脂肪垫(iWAT)(-40.5%)或gWAT(-31.8%)质量。RNA测序显示,与假手术小鼠相比,PDAC小鼠gWAT中有572个差异表达基因。下调基因(n = 126)与脂肪生成相关(校正p = 0.05),且PDAC小鼠gWAT中脂肪生成主调节因子和的表达降低。免疫组织化学显示,PDAC小鼠gWAT(+74.9%)和iWAT(+41.2%)中HuR染色增加。抑制HuR结合可恢复再喂食动物的脂肪生成,同时iWAT质量增加(+131.7%)以及调节脂肪生成的基因(、、、、)增加。
我们的研究突出了脂肪合成代谢不足是用PDAC条件培养基处理的3T3-L1脂肪细胞和OT-PDAC小鼠消瘦的驱动因素。破坏HuR结合的小分子KH3足以恢复脂肪生成和脂肪生成基因表达,并防止脂肪消耗。这突出了HuR作为癌症恶病质中脂肪合成代谢的潜在可靶向调节节点。